Surprisingly, Guan and colleagues (2024) found that combined treatment with anti-TIGIT and anti-PD-L1 increased Tregs and TAMs in tumors, yet correlated with improved ORR and OS in patients with NSCLC [55]. Here, CD274 is linked to non-small cell lung carcinoma.